Theralase Technologies Inc. (TSXV:TLT)
Canada · Delayed Price · Currency is CAD 0.2950
+0.0100 (3.51%)
Mar 2, 2026, 10:30 AM EST
Theralase Technologies Employees
Theralase Technologies had 20 employees as of December 31, 2017. The number of employees decreased by 14 or -41.18% compared to the previous year.
Employees
20
Change
-14
Growth
-41.18%
Revenue / Employee
50.05K CAD
Profits / Employee
-217.66K CAD
Market Cap
75.53M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2017 | 20 | -14 | -41.18% |
| Dec 31, 2015 | 34 | - | - |
Theralase Technologies News
- 10 days ago - Correcting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress - Newsfile Corp
- 13 days ago - Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress - Newsfile Corp
- 20 days ago - Theralase(R) Bladder Cancer Clinical Data to be Presented at the 2026 American Urological Association Annual Meeting - Newsfile Corp
- 26 days ago - Theralase(R) Provides Update on Bladder Cancer Clinical Study - Newsfile Corp
- 7 weeks ago - Ferring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer - Newsfile Corp
- 7 weeks ago - Ferring Pharmaceuticals and Theralase® Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer - Business Wire
- 2 months ago - Theralase(R) Closes $1.3 M Non-Brokered Private Placement - Newsfile Corp
- 2 months ago - Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing - Newsfile Corp